To Evaluate the Safety, Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory Cancer

This study has been completed.
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Spectrum Pharmaceuticals, Inc Identifier:
First received: October 15, 2010
Last updated: May 26, 2015
Last verified: May 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2014
  Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)